The program opened with a welcome address from Craig Grant, VP and General Manager, Cambridge, who set the tone for a day focused on innovation and problem‑solving.
“Cambridge Science Day is an opportunity to connect directly with our customers and peers, share scientific insight, and showcase the depth of expertise within the Veranova team,” said Craig Grant.
A wide‑ranging agenda reflected the growing complexity of early API development. Presentations covered topics including polymer cocrystals, mechanochemistry, amorphous solid dispersions, peptide crystallization strategies, and advanced drying processes, highlighting both emerging challenges and practical solutions in pharmaceutical development.
Guest speakers included Dr Neil Stevenson of CMC Logic Consultancy, who shared insights into the manufacture of BEN‑28010; Frank Theodosiou of Durham University, who discussed mapping solvate phase boundaries using mechanochemistry; and Dr Thomas Vetter, Professor of Pharmaceutical Process Engineering at FHNW, who explored advanced humid drying processes.
In the afternoon, attendees had the opportunity to tour our laboratories and engage with our experts over poster sessions. The day concluded with a drinks reception, allowing participants to continue conversations and build new relationships.
Cambridge Science Day 2026 reinforced Veranova’s commitment to scientific excellence and collaboration, offering a platform to share expertise, exchange ideas and strengthen partnerships across the pharmaceutical and chemical sciences community.
